Vitestro’s Aletta system uses multimodal imaging, Doppler ultrasound and AI to take samples in less than 3 minutes.

Autonomous blood-drawing devices could help address phlebotomist shortages ...

One phlebotomist can oversee up to three Aletta units at once, which the FDA says may help address a shortage of trained blood draw technicians ...

UTRECHT, The Netherlands, March 6, 2025 /PRNewswire/ -- Vitestro, a pioneer in medical robotics, proudly reveals the name of its autonomous blood drawing device: Aletta™, the first autonomous robotic ...

UTRECHT, The Netherlands, Jan. 12, 2026 /PRNewswire/ -- Vitestro, a pioneer in medical robotics advancing automated diagnostic blood collection, today announced the launch of its new corporate website ...

The Aletta from startup Vitestro uses near-infrared light and ultrasound to find veins, then executes the blood collection process from tourniquet application to bandaging.

Vitestro has raised $70m to advance development and broaden the commercialisation of its autonomous blood-drawing robot. The Dutch company’s oversubscribed Series B financing round saw a mix of ...

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult ...

On Wednesday, the U.S. Food and Drug Administration authorized the first robotic blood-draw device, addressing the shortage of phlebotomists throughout the nation. The Aletta is the first standalone ...

Vitestro – a pioneer in autonomous robotic venous access and blood drawing – announced the appointment of Bob Gerberich as Chief Commercial Officer for North America. With this role, Gerberich will ...

The Food and Drug Administration granted marketing authorization to Vitestro for Aletta, a robotic blood draw device. The FDA said the Aletta is the first standalone robotic device that can draw blood ...